Shuya Li
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial.
Journal: Stroke and vascular neurology
Published: July 23, 2025
Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial.
Journal: Stroke and vascular neurology
Published: July 22, 2025
Colchicine for preventing stroke in patients with and without intracranial atherosclerotic stenosis: a prespecified analysis of a randomized clinical trial.
Journal: EClinicalMedicine
Published: February 10, 2025
Chinese stroke association guidelines on reperfusion therapy for acute ischaemic stroke 2024.
Journal: Stroke and vascular neurology
Published: December 20, 2024
Current gaps in acute reperfusion therapies.
Journal: Current opinion in neurology
Published: November 28, 2024
Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial.
Journal: Stroke and vascular neurology
Published: September 16, 2024
Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial.
Journal: The Lancet. Neurology
Published: September 11, 2024
EFfects of Y-6 SUblingual Tablets for PaTients with AcUte Ischemic StRokE (FUTURE): a phase II, randomised, double-blind, double-dummy, placebo-controlled, parallel trial.
Journal: Stroke and vascular neurology
Published: August 28, 2024
Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial.
Journal: BMJ (Clinical research ed.)
Published: June 26, 2024
RhPro-UK in acute ischemic stroke within 4.5 h of stroke onset trial-2 (the PROST-2 study): Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial.
Journal: International journal of stroke : official journal of the International Stroke Society
Published: June 22, 2024
Safety and efficacy of GD-11 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Journal: Stroke and vascular neurology
Published: April 18, 2024
Last Updated: 09/26/2026